Related by context. Frequent words. (Click for all words.) 67 Initiates Phase II 66 Epratuzumab 65 Panzem R 65 Aurexis 65 liposomal formulation 64 Receives Orphan Drug Designation 64 Golimumab 64 CCX# 64 Metastatic Melanoma 64 Factor VIIa 64 TLR9 agonist 64 Nanobody 64 anticancer compound 64 ALN TTR 64 ATL# [001] 63 Onalta 63 Alzhemed TM 63 forodesine 63 topical anti infective 63 Denufosol 62 PEG SN# 62 Shigamabs ® 62 GRNVAC1 62 Chemokine Therapeutics 62 Diamyd R 62 Allovectin 7 R 62 Pivotal Study 62 BZL# 62 Guanilib 62 AEG# 62 Sym# 62 Aliskiren 62 Hepatitis C Virus HCV 62 BrachySil 62 Traficet EN 62 orally bioavailable 62 DermaVir 62 CR# vcMMAE 61 immunotherapeutics 61 Anthim 61 WILEX 61 Diamyd ® 61 MKC# 61 Ziopharm 61 Drug Candidate 61 humanized antibody 61 rilonacept 61 Daclizumab 61 Veronate 61 IMC #B 61 proteasome inhibitor 61 Cetrorelix 61 IND submission 61 CYC# 61 Proxinium TM 61 refractory chronic lymphocytic 61 OncoVEX GM CSF 61 Presents Positive 61 Phase III Clinical Trial 61 SAR# [004] 61 therapeutic monoclonal antibodies 61 Microplasmin 61 inhaled formulation 61 pafuramidine 60 faropenem 60 Azedra 60 Ferumoxytol 60 ThermoDox R 60 FDA Orphan Drug 60 cancer immunotherapies 60 JAK3 60 Mipomersen 60 ALN VSP 60 Icatibant 60 Initiate Phase 60 ALN TTR# 60 siRNA therapeutics 60 KaloBios 60 HuMax CD4 60 NEUMUNE 60 Tesetaxel 60 RNAi Therapeutics 60 prophylactic vaccine 60 ImmunoCellular Therapeutics 60 MOZOBIL 60 Orphan Drug status 60 KRN# 60 Zoraxel 60 Preclinical Data 60 BEXXAR 60 Pivotal Phase III 60 fusion inhibitor 60 Carfilzomib 60 gets USFDA nod 60 INCB# [001] 60 MAXY G# 60 JAK1 60 KNS # 60 targeting CD# 60 Soliris TM eculizumab 60 Loramyc R